-
Innovation Ranking
NewInnovation Ranking – Evonik Industries AG
Evonik Industries AG (Evonik), a subsidiary of RAG-Stiftung, is a specialty chemical company. Its product portfolio includes surfactants, polymers, resins, additives and others. The company’s products find application in various markets including agriculture, renewable energy, paints and coatings, paper and printings, metal and oil products, electrical and electronics, food and animal feed, consumer and personal care products, pharmaceuticals, plastics and rubber, automotive and construction. It also offers process technology, technical, logistics, utilities and waste management, and engineering services. Evonik has...
-
Product Insights
Ryburg-Schworstadt
Ryburg-Schworstadt is a Hydro project located in Aargau, Switzerland. The project is owned by Alpiq Holding AG; Axpo Power AG; Canton of Aargau; EnBW Energie Baden-Wurttemberg AG; Energiedienst AG; Evonik Industries AG. The project came online in 1930. Empower your strategies with our Ryburg-Schworstadt report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and...
-
Product Insights
Ryburg-Schworstadt Germany
Ryburg-Schworstadt Germany is a Hydro project located in Baden-Wurttemberg, Germany. The project is owned by Alpiq Holding AG; Axpo Holding AG; EnBW Energie Baden-Wurttemberg AG; Energiedienst AG; Evonik Industries AG. The project came online in 1930. Empower your strategies with our Ryburg-Schworstadt Germany report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays....
-
Sector Analysis
Contract Pharmaceutical Dose Manufacturing Industry – Composition, Size, Market Share and Outlook, 2023 Edition
Contract Pharmaceutical Dose Manufacturing Industry Overview The total dose CMO contract revenue in 2022 represented significant growth over 2021 revenue. The growth rate was the highest recorded since 2011 for commercial contract dose manufacturing revenues, and surprisingly adds to the strong growth experienced in 2021, despite demand for COVID-19 vaccines and therapies waning in 2022. The Contract Pharmaceutical Dose Manufacturing Industry report is a comprehensive look at the finished dose contract manufacturing landscape in 2023. It includes an analysis of...
-
Company Insights
Innovation and Patenting activity of Evonik Industries AG Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Evonik Industries AG Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Company Profile
Evonik Industries AG – Company Profile
Evonik Industries AG (Evonik), a subsidiary of RAG-Stiftung, is a specialty chemical company. Its product portfolio includes surfactants, polymers, resins, additives and others. The company’s products find application in various markets including agriculture, renewable energy, paints and coatings, paper and printings, metal and oil products, electrical and electronics, food and animal feed, consumer and personal care products, pharmaceuticals, plastics and rubber, automotive and construction. It also offers process technology, technical, logistics, utilities and waste management, and engineering services. Evonik has...
Add to Basket -
Sector Analysis
3D Printing Market Size, Share and Trends Analysis by Component Type, Vertical Type, Region and Segment Forecast to 2026
3D Printing Market Overview The 3D printing market size is estimated to be $23.2 billion in 2023 and expected to grow at a compound annual growth rate (CAGR) of more than 22% over the forecast period. The 3D printing industry is on an upwards curve, with growing usage in manufacturing, alongside injection molding and computer numerical control machining. The use of polymers, particularly plastics, in 3D printing still exceeds metals, but the gap is narrowing, and metals could outstrip polymers...
-
Sector Analysis
Orthobiologics Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Orthobiologics are biomaterials used in orthopedic surgery as an adjunct to faster fusion and healing of the bone. The orthobiologics category covers bone graft substitutes, bone growth stimulators, cartilage repair and viscosupplementation products. The orthobiologics pipeline market research report provides comprehensive information about the orthobiologics pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Sector Analysis
Contract Injectable Packaging Trends in the Bio/Pharma Industry
Injectables and their packaging requirements are very important to marketed treatments given the volume of vaccines required to tackle the COVID-19 pandemic and the rising number of biologics in development pipelines and on the market. Most injectable drugs in the development pipeline are biologics, which will become increasingly approved and more established in the treatment landscape in the future. The top contract packaging organizations (CPOs) for injectables by the number of contracts are standalone packagers along with large CMOs which...
-
Sector Analysis
Contract Small Molecule API Manufacturing Industry by the Numbers – 2021 Edition
According to the Global Data’s Drugs database, it indicates that maximum of the marketed drugs is found to be small molecules, despite many of the prominent contract manufacturing organizations (CMOs) investing in advanced therapy medicinal product (ATMP) capabilities in recent years and an increasing use of biologic APIs in both the pipeline and among marketed drugs. With the increase in high potency small molecule APIs, has been driven by the rise of oncology pipeline drugs coupled with small or virtual...